Wells Fargo Raises MetLife (MET) Price Target to $110

Wells Fargo has reaffirmed its Overweight rating on MetLife with a price target of $110, a 8.18% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:06 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Wells Fargo raised its price target on MetLife, Inc. ($MET) to $110 from $109 on October 12, 2026, and rates the stock "Overweight".

Since the rating, $MET is up 0.6% to date (from the $100.17 close on Oct 12, 2026).

MET MetLife, Inc.

$100.76 +28.11% year to date

Daily close · Oct 16, 2026

Key Points

On October 12, 2026, Wells Fargo reiterated its Overweight rating on MetLife, Inc. with a price target set at $110.
Wells Fargo's $110 price target implies 8.18% upside from MetLife, Inc.'s ($MET) current $101.69 share price.
MetLife's shares recently traded around $101.69, which is about 7.6% below the analyst's target.
The company is expected to report earnings on November 9, 2026, following a year-over-year revenue growth of 10.5%.

Get $MET trade alerts by text

We text you when insiders, Congress or big funds trade $MET. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated MetLife, Inc. alert may contain errors. Disclosures

Wells Fargo has reiterated its Overweight rating on MetLife, Inc. (NYSE: MET) on October 12, 2026, maintaining a price target of $110. This marks a slight increase from the previous target of $109. With shares currently trading around $101.69 as of October 16, 2026, they are approximately 7.6% below the set target.

Other Institutional Activity in MetLife

Several other institutional investors have also been active in MetLife. Blackrock Inc. holds about 51.8 million shares worth approximately $5.2 billion, having added 365,095 shares recently. State Street Corporation owns about 25.3 million shares valued at around $2.6 billion, with a slight increase of 116,017 shares. In contrast, Dodge & Cox Inc. reduced its holdings by 2.7 million shares, resulting in a total of about 48.4 million shares valued at approximately $4.9 billion.

MetLife, Inc. Stock Up 1.4%

Currently, MetLife shares are trading below the analyst price target, which may indicate potential for growth if the target is met. The stock's recent performance shows it is positioned well, trading around $101.69, while the 52-week high has been much higher, suggesting room for recovery.

12-month forecast

$MET price target

MetLife, Inc. daily closes and this analyst's $110 target. Not advice.

Recent Earnings

For the trailing twelve months, MetLife reported a revenue of approximately $79.4 billion and an earnings per share (EPS) of $5.22. The company has shown a 10.5% year-over-year revenue growth, indicating a solid performance in its sector.

Analysts Set New Price Targets

In addition to Wells Fargo, several firms have maintained their ratings on MetLife. On October 5, 2026, TD Cowen maintained a Buy rating with a target of $110, up from $105. UBS also kept a Buy rating with a target of $110, while Mizuho maintained an Outperform rating but adjusted its target from $112 to $109. Barclays raised its target significantly from $97 to $111 while maintaining its Overweight rating.

About MetLife

MetLife, Inc. is a global financial services company based in New York, NY. It provides a range of insurance products, annuities, and asset management services. The company operates in various regions, including Asia, Latin America, and Europe, focusing on delivering employee benefits and retirement solutions.

Bottom Line

Investors should keep an eye on MetLife's upcoming earnings report scheduled for November 9, 2026, as it may provide further insights into the company's performance. With Wells Fargo's reaffirmation of its Overweight rating and the recent target adjustments from other analysts, the stock remains a focal point in the financial services sector.